Please login to the form below

Not currently logged in
Email:
Password:

hypertriglyceridaemia

This page shows the latest hypertriglyceridaemia news and features for those working in and with pharma, biotech and healthcare.

FDA approves AZ’s fish oil drug

FDA approves AZ’s fish oil drug

The FDA approval covers its use as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridaemia. ... According to AZ, nearly four million adults in the US currently have severe hypertriglyceridaemia.

Latest news

  • FDA to review AZ's fish oil drug Epanova FDA to review AZ's fish oil drug Epanova

    FDA to review AZ's fish oil drug Epanova. Hypertriglyceridaemia treatment acquired as part of Omthera takeover. ... By tackling triglycerides, these oils can have benefits for patients with severe hypertriglyceridaemia, which can lead to coronary artery

  • FDA gives priority review status to BMS/ AZ's metreleptin FDA gives priority review status to BMS/ AZ's metreleptin

    Amylin filed for approval of metreleptin in 2010 as a treatment for diabetes and/or hypertriglyceridaemia in LD patients, using a rolling biologics license application (BLA) that allowed the various parts

  • Gene therapy: the promise comes closer Gene therapy: the promise comes closer

    Patients with LPLD are unable to metabolise chylomicrons (triglyceride-rich lipoproteins or fat particles that circulate in the blood after a meal), resulting in severe hypertriglyceridaemia and painful and potentially

  • Amylin and Takeda halt obesity drug study

    In late 2010, Amylin began submission of a rolling US Biologics Licensing Application for metreleptin as monotherapy to treat diabetes and/or hypertriglyceridaemia (high levels of triglycerides in the bloodstream) in

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics